Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 14/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 10/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 9/20 | 0.50 |
| ▸ | HTR2A | P28223 | 2/20 | 0.50 |
| ▸ | HTR2B | P41595 | 2/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.50 |
| ▸ | GBA1 | P04062 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | HTR3A | P46098 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL682819 | 1.00 | SLC6A2 (0.50) | SLC6A2SLC6A3SLC6A4HTR2AHTR2B | |
| SCHEMBL1552999 | 1.00 | SLC6A2 (0.50) | SLC6A2SLC6A3SLC6A4HTR2AHTR2B | |
| Methane SCHEMBL27798790 | 0.98 | SLC6A2 (0.49) | SLC6A2SLC6A3SLC6A4HTR2AHTR2B | |
| Hydrochloric Acid SCHEMBL4772964 | 0.98 | SLC6A2 (0.49) | SLC6A2SLC6A3SLC6A4HTR2AHTR2B | |
| Trifluoroacetic Acid SCHEMBL2267360 | 0.87 | SLC6A2 (0.46) | SLC6A2SLC6A3SLC6A4HTR2AHTR2B | |
| SCHEMBL1553169 | 0.86 | MAOB (0.50) | SLC6A2SLC6A3SLC6A4HTR2AHTR2B | |
| SCHEMBL1553074 | 0.86 | MAOB (0.50) | SLC6A2SLC6A3SLC6A4HTR2AHTR2B | |
| SCHEMBL8924483 | 0.84 | DRD4 (0.51) | SLC6A2SLC6A3SLC6A4HTR2AHTR2B | |
| SCHEMBL78044 | 0.84 | DRD4 (0.51) | SLC6A2SLC6A3SLC6A4HTR2AHTR2B | |
| SCHEMBL28529628 | 0.84 | SLC6A2 (0.41) | SLC6A2SLC6A3SLC6A4HTR2AHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109731540-B | Preparation method of porous lanthanum oxide | 龙岩学院 | 2021-10-22 | — | — | CN | claimed |
| US-9328300-B2 | Method, apparatus and chemical products for treating petroleum equipment | FERRARA MARCELLO (IT) | 2016-05-03 | — | — | US | claimed |
| EP-1910320-A2 | INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF | Mitsubishi Tanabe Pharma Corporation (JP) | 2008-04-16 | — | — | EP | claimed |
| WO-2007011065-A2 | INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-01-25 | — | — | WO | claimed |
| CN-1147254-A | Prodrugs of morpholine tachykinin receptor antagonists | MERCK & CO INC (US) | 1997-04-09 | — | — | CN | claimed |
| US-20240262832-A1 | SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF | VANQUA BIO, INC. (US) | 2024-08-08 | — | — | US | disclosed |
| US-20240124443-A1 | PLASMIN INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | SCINNOHUB PHARMACEUTICAL CO., LTD (CN) | 2024-04-18 | — | — | US | disclosed |
| EP-4329881-A1 | SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF | Vanqua Bio, Inc. (US) | 2024-03-06 | — | — | EP | disclosed |
| CN-117642404-A | Small molecule modulators of glucocerebrosidase activity and uses thereof | 凡况生化公司 | 2024-03-01 | — | — | CN | disclosed |
| EP-4289850-A1 | PLASMIN INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Scinnohub Pharmaceutical Co., Ltd (CN) | 2023-12-13 | — | — | EP | disclosed |
| EP-4289850-A1 | PLASMIN INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Scinnohub Pharmaceutical Co., Ltd (CN) | 2023-12-13 | — | — | EP | disclosed |
| CN-111548269-B | Preparation method of diaryl methane structural compound | 兰州大学 | 2023-10-27 | — | — | CN | disclosed |
| US-5593983-A | PREPARATION BY REACTING SUBSTITUTED /THIO/MORPHOLINE OR SALT AND 2,3-EPOXYANDROSTANE OR 2,3-EPOXY-19-NOR-ANDROSTANE; USE TO INDUCE ANESTHESIA | AKZO NOBEL N.V. (NL) | 1997-01-14 | — | — | US | disclosed |
| EP-0730593-A1 | MORPHOLINE DERIVATIVES AS DOPAMINE RECEPTOR SUBTYPE LIGANDS | MERCK SHARP & DOHME LTD. (GB) | 1996-09-11 | — | — | EP | disclosed |
| WO-1995023798-A1 | PRODRUGS OF MORPHOLINE TACHYKININ RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1995-09-08 | — | — | WO | disclosed |
| WO-1995016679-A1 | MORPHOLINE AND THIOMORPHOLINE TACHYKININ RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1995-06-22 | — | — | WO | disclosed |
| EP-0656365-A1 | Substituted 2beta-morpholinoandrostane derivatives | Akzo Nobel N.V. (NL) | 1995-06-07 | — | — | EP | disclosed |
| WO-1995014690-A1 | MORPHOLINE DERIVATIVES AS DOPAMINE RECEPTOR SUBTYPE LIGANDS | MERCK SHARP & DOHME LIMITED (GB) | 1995-06-01 | — | — | WO | disclosed |
| US-4328226-A | Quaternary benzylmorpholine salts having formyl or nitrile substituents in a ring and fungicidal compositions | INSTYTUT PRZEMYSLU ORGANICZNEGO & POLITECHNIKA WROCLAWSKA (PL) | 1982-05-04 | — | — | US | disclosed |
| US-4328226-A | Quaternary benzylmorpholine salts having formyl or nitrile substituents in a ring and fungicidal compositions | INSTYTUT PRZEMYSLU ORGANICZNEGO & POLITECHNIKA WROCLAWSKA (PL) | 1982-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124443-A1 | PLASMIN INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | F2, PLG, PLAT | SLC6A2 3638/4885SLC6A3 3501/4885SLC6A4 3420/4885 |
| US-20240262832-A1 | SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF | GBA1, GAA, GBA2 | SLC6A2 1368/4885SLC6A3 571/4885SLC6A4 2270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.